Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Contraception and Contraceptive Drugs

Free Subscription Articles published in Obstet Gynecol Retrieve available abstracts of 76 articles: HTML format

Single Articles

May 2023
1. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
   Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
   Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
   PubMed     Abstract available
   
   
   
2. ARORA KS, Chua A, Miller E, Boozer M, et al
   Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
   Obstet Gynecol. 2023;141:918-925.
   PubMed     Abstract available
   
   
   
3. NEBLETT MF 2ND, Stewart EA
   Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
   Obstet Gynecol. 2023;141:901-910.
   PubMed     Abstract available
   
   
   April 2023
4. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
   Remote Provision of Medication Abortion and Contraception Through Telemedicine.
   Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
   PubMed     Abstract available
   
   
   
5. CREININ MD, Jensen JT, Chen MJ, Black A, et al
   Combined Oral Contraceptive Adherence and Pregnancy Rates.
   Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
   PubMed     Abstract available
   
   
   
6. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
   Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
   Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
   PubMed     Abstract available
   
   
   
7. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
   Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
   Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
   PubMed     Abstract available
   
   
   
8. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
   Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
   Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
   PubMed     Abstract available
   
   
   
9. 
   Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
   Obstet Gynecol. 2023;141:866-872.
   PubMed     Abstract available
   
   
   March 2023
10. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    PubMed     Abstract available
    
    
    February 2023
11. MADISON AM, Powers D, Maslowsky J, Goyal V, et al
    Association Between Publicly Funded Contraceptive Services and the Abortion Rate in Texas, 2010-2015.
    Obstet Gynecol. 2023;141:361-370.
    PubMed     Abstract available
    
    
    January 2023
12. PEARLMAN SHAPIRO M, Dethier D, Kahili-Heede M, Kaneshiro B, et al
    No-Test Medication Abortion: A Systematic Review.
    Obstet Gynecol. 2023;141:23-34.
    PubMed     Abstract available
    
    
    December 2022
13. WU J, Trahair E, Happ M, Swartz J, et al
    TikTok, #IUD, and User Experience With Intrauterine Devices Reported on Social Media.
    Obstet Gynecol. 2022 Dec 6. doi: 10.1097/AOG.0000000000005027.
    PubMed     Abstract available
    
    
    November 2022
14. UWANAKA O, Qureshey E, Wagner SM, Gupta M, et al
    Temporal Changes in Counseling for and Use of Emergency Contraception.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00611.
    PubMed     Abstract available
    
    
    
15. ANTHONY MS, Zhou X, Schoendorf J, Reed SD, et al
    Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00606.
    PubMed     Abstract available
    
    
    October 2022
16. BAKER CC, Creinin MD
    Long-Acting Reversible Contraception.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00599.
    PubMed     Abstract available
    
    
    
17. COLEMAN-MINAHAN K, Boniface ER, Fuentes-Rivera E, Saavedra-Avendano B, et al
    Patterns in Contraceptive Use Among Women of Mexican Origin in the United States and in Mexico.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00582.
    PubMed     Abstract available
    
    
    
18. ROMANSKI PA, Gelvin B, Bortoletto P, Rosenwaks Z, et al
    Live-Birth Outcomes Among Women With Infertility and Anti-Mullerian Hormone Levels of 0.3 ng/mL or Lower.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00590.
    PubMed     Abstract available
    
    
    
19. PANKO TL
    Reproductive Justice for the Deaf Community.
    Obstet Gynecol. 2022;140:560-564.
    PubMed     Abstract available
    
    
    September 2022
20. 
    General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.
    Obstet Gynecol. 2022;140:528-541.
    PubMed     Abstract available
    
    
    
21. CIRUCCI C, Harrison D, Francis C
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;140:519.
    PubMed    
    
    
    
22. COCKRUM RH, Soo J, Ham SA, Cohen KS, et al
    Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
    Obstet Gynecol. 2022;140:477-487.
    PubMed     Abstract available
    
    
    August 2022
23. ELGEMARK K, Graner S, McTaggart J, Ramirez Lofstrom J, et al
    The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
    Obstet Gynecol. 2022;140:227-233.
    PubMed     Abstract available
    
    
    July 2022
24. MARTINEZ OP, Wilder L, Seal P
    Ultrasound-Guided Compared With Non-Ultrasound-Guided Placement of Immediate Postpartum Intrauterine Contraceptive Devices.
    Obstet Gynecol. 2022;140:91-93.
    PubMed     Abstract available
    
    
    
25. EDELMAN AB, Hennebold JD, Bond K, Lim JY, et al
    Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;140:48-54.
    PubMed     Abstract available
    
    
    June 2022
26. ROE AH, Abernathy A, Flynn AN, McAllister A, et al
    Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
    Obstet Gynecol. 2022;139:1149-1151.
    PubMed     Abstract available
    
    
    
27. BIGGS MA, Ehrenreich K, Morris N, Blanchard K, et al
    Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
    Obstet Gynecol. 2022;139:1111-1122.
    PubMed     Abstract available
    
    
    May 2022
28. PAKEY J, Nassim JS, Reynolds RV
    Hormonal Intrauterine Devices and Acne.
    Obstet Gynecol. 2022;139:919-921.
    PubMed    
    
    
    
29. PETERSON SF, Lerma K, Shaw KA, Blumenthal PD, et al
    Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions.
    Obstet Gynecol. 2022;139:907-909.
    PubMed    
    
    
    
30. HARMON QE, Patchel SA, Zhao S, Umbach DM, et al
    Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Obstet Gynecol. 2022;139:797-807.
    PubMed     Abstract available
    
    
    
31. RODRIGUEZ MI, Manibusan B, Kaufman M, McConnell KJ, et al
    Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
    Obstet Gynecol. 2022;139:781-787.
    PubMed     Abstract available
    
    
    
32. GOLDBERG AB, Fulcher IR, Fortin J, Hofer RK, et al
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;139:771-780.
    PubMed     Abstract available
    
    
    
33. KOPP-KALLNER H, Linder M, Cesta CE, Segovia Chacon S, et al
    Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
    Obstet Gynecol. 2022;139:764-770.
    PubMed     Abstract available
    
    
    April 2022
34. LAZORWITZ A, Pena M, Sheeder J, Teal S, et al
    Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2022;139:579-587.
    PubMed     Abstract available
    
    
    
35. QURESHEY EJ, Chauhan SP, Wagner SM, Batiste O, et al
    Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;139:571-578.
    PubMed     Abstract available
    
    
    March 2022
36. BRANT AR, Batur P, Arrigain S, Lopez R, et al
    Out-of-Pocket Expenditures for Contraceptives During State Medicaid Expansion, 2013-2016.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00411.
    PubMed    
    
    
    
37. BURGER T, Li J, Zhao Q, Schreiber CA, et al
    Association of Obesity With Longer Time to Pregnancy.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00400.
    PubMed     Abstract available
    
    
    
38. GARIEPY AM, Lewis C, Zuckerman D, Tancredi DJ, et al
    Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.
    Obstet Gynecol. 2022;139:423-432.
    PubMed     Abstract available
    
    
    
39. DANVERS AA, Evans TA
    Risk of Sterilization Regret and Age: An Analysis of the National Survey of Family Growth, 2015-2019.
    Obstet Gynecol. 2022;139:433-439.
    PubMed     Abstract available
    
    
    February 2022
40. STEENLAND MW, Rodriguez MI, Cohen JL
    Changes in the Supply Duration of Combined Oral Contraception During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2022 Feb 3. pii: 00006250-990000000-00386.
    PubMed    
    
    
    
41. 
    Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1.
    Obstet Gynecol. 2022;139:350-353.
    PubMed    
    
    
    November 2021
42. MAGNUSSON BM, Christensen SR, Tanner AB, Eyring JB, et al
    Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00334.
    PubMed     Abstract available
    
    
    October 2021
43. BRANT AR, Kollikonda S, Yao M, Mei L, et al
    Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Obstet Gynecol. 2021 Oct 7. pii: 00006250-990000000-00308.
    PubMed     Abstract available
    
    
    
44. BURLANDO AM, Flynn AN, Gutman S, McAllister A, et al
    The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2021;138:574-577.
    PubMed     Abstract available
    
    
    
45. BOUMA-JOHNSTON H, Arora KS
    Website Review of Variation in Individual State Medicaid Sterilization Policies.
    Obstet Gynecol. 2021;138:578-579.
    PubMed    
    
    
    
46. BOHN JA, Bullard KA, Rodriguez MI, Ecker AM, et al
    Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2021;138:557-564.
    PubMed     Abstract available
    
    
    August 2021
47. WU JP, Zhang J, McKee M, Akobirshoev I, et al
    Contraceptive Provision and Quality Care Measures for Insured Individuals in Massachusetts Who Are Deaf or Hard of Hearing.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00251.
    PubMed     Abstract available
    
    
    
48. SCHAUB AM, Pisarska MD, Wright KN
    Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00258.
    PubMed     Abstract available
    
    
    
49. 
    Access to Postabortion Contraception: ACOG Committee Opinion, Number 833.
    Obstet Gynecol. 2021;138:e91-e95.
    PubMed     Abstract available
    
    
    
50. 
    Access to Postabortion Contraception: ACOG Committee Opinion Summary, Number 833.
    Obstet Gynecol. 2021;138:324-325.
    PubMed     Abstract available
    
    
    July 2021
51. BAKENRA A, Gero A, Sanders J, Simmons R, et al
    Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    Obstet Gynecol. 2021;138:79-84.
    PubMed     Abstract available
    
    
    
52. ARORA KS, Ponsaran R, Morello L, Katabi L, et al
    Obstetrician-Gynecologists' Practices in Postpartum Sterilization Without a Valid Medicaid Consent Form.
    Obstet Gynecol. 2021;138:66-72.
    PubMed     Abstract available
    
    
    June 2021
53. 
    Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol. 2021;137:e100-e115.
    PubMed     Abstract available
    
    
    
54. 
    Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.
    Obstet Gynecol. 2021;137:e169-e176.
    PubMed     Abstract available
    
    
    May 2021
55. HAMDAOUI N, Cardinale C, Fabre C, Baumstarck K, et al
    Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00191.
    PubMed     Abstract available
    
    
    April 2021
56. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    PubMed     Abstract available
    
    
    
57. ALLANSON ER, Copson S, Spilsbury K, Criddle S, et al
    Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00158.
    PubMed     Abstract available
    
    
    
58. COHEN M, Edelman A, Bellussi F, Berghella V, et al
    Cochrane Review Summaries-April 2021.
    Obstet Gynecol. 2021;137:747-749.
    PubMed     Abstract available
    
    
    March 2021
59. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    PubMed     Abstract available
    
    
    
60. BORAAS CM, Sanders JN, Schwarz EB, Thompson I, et al
    Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00136.
    PubMed    
    
    
    
61. 
    Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
    Obstet Gynecol. 2021;137:e75-e88.
    PubMed     Abstract available
    
    
    February 2021
62. AKTURK HK
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    PubMed     Abstract available
    
    
    
63. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.
    PubMed    
    
    
    January 2021
64. 
    Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    PubMed     Abstract available
    
    
    December 2020
65. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    PubMed     Abstract available
    
    
    November 2020
66. 
    Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    PubMed     Abstract available
    
    
    
67. 
    Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    PubMed     Abstract available
    
    
    October 2020
68. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    PubMed     Abstract available
    
    
    
69. 
    Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    PubMed     Abstract available
    
    
    September 2020
70. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    PubMed     Abstract available
    
    
    August 2020
71. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    PubMed     Abstract available
    
    
    
72. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    PubMed     Abstract available
    
    
    June 2020
73. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.
    PubMed    
    
    
    
74. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.
    PubMed    
    
    
    
75. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    PubMed     Abstract available
    
    
    
76. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: